Soichi Toyama

The Association of Powder Process Industry & Engineering is a committee focused on powder industrial technology. The Japanese company's description provides standard information related to the association.

Fuji Chemical Co. Ltd. is a Japanese company that manufactures chemical products.

Fuji Chemical Co., Ltd. is a top domestic manufacturer of soda silicate based in Osaka, Japan. The Japanese company offers a wide range of products such as synthetic silica, silica-zols, ground improvement materials, and various inorganic binders. The company has a technical center in Gifu prefecture and is dedicated to developing new products such as liquid type silica water, which is a turf supplement. Additionally, they have developed consignment materials called House Form®. The company was founded in 1932 and is focused on technical cooperation with customers to explore new possibilities for soda silicate.

Part of ITOCHU Corp., ITOCHU REIT Management Co., Ltd. is a comprehensive asset management company based in Tokyo, Japan. The Japanese company specializes in asset management of real estate funds such as J-REIT and private REIT.

Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan.

SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe.